1. Home
  2. GALT vs FRA Comparison

GALT vs FRA Comparison

Compare GALT & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

N/A

Current Price

$2.90

Market Cap

397.3M

Sector

Health Care

ML Signal

N/A

Logo Blackrock Floating Rate Income Strategies Fund Inc

FRA

Blackrock Floating Rate Income Strategies Fund Inc

N/A

Current Price

$9.97

Market Cap

367.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GALT
FRA
Founded
2000
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
397.3M
367.5M
IPO Year
2008
2003

Fundamental Metrics

Financial Performance
Metric
GALT
FRA
Price
$2.90
$9.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 185.4K
167.3K
Earning Date
11-16-2026
01-01-0001
Dividend Yield
N/A
★ 11.06%
EPS Growth
★ 36.84
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$9.65
52 Week High
$7.13
$12.23

Technical Indicators

Market Signals
Indicator
GALT
FRA
Relative Strength Index (RSI) 35.26 38.51
Support Level $2.78 $9.65
Resistance Level $3.30 $11.20
Average True Range (ATR) 0.30 0.12
MACD -0.03 -0.01
Stochastic Oscillator 5.13 4.60

Price Performance

Historical Comparison
GALT
FRA

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a closed-end management investment company. Its investment objective is to provide shareholders with high current income and such preservation of capital as is consistent with investment in a diversified, leveraged portfolio consisting of floating rate debt securities and instruments. The Fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its managed assets in floating rate debt securities, including floating or variable rate debt securities that pay interest at rates that adjust whenever a specified interest rate changes and/or which reset on predetermined dates (such as the last day of a month or calendar quarter).

Share on Social Networks: